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Abstract
The ST-segment and adjacent T-wave (ST-T wave) amplitudes of the electrocardiogram are quantitative characteristics of
cardiac repolarization. Repolarization abnormalities have been linked to ventricular arrhythmias and sudden cardiac death.We
performed the ﬁrst genome-wide associationmeta-analysis of ST-T-wave amplitudes in up to 37 977 individuals identifying 71
robust genotype–phenotype associations clustered within 28 independent loci. Fifty-four genes were prioritized as candidates
underlying the phenotypes, including geneswith established roles in the cardiac repolarization phase (SCN5A/SCN10A, KCND3,
KCNB1, NOS1AP and HEY2) and others with as yet undeﬁned cardiac function. These associations may provide insights in the
spatiotemporal contribution of genetic variation inﬂuencing cardiac repolarization andprovidenovel leads for future functional
follow-up.
Introduction
Duration of cardiac repolarization has been previously studied by
genome-wide association studies (GWAS) and led to the discov-
ery of 35 associated loci (1). However, abnormalities of repolariza-
tionarenot limited to changes induration, but are also captured by
changes in amplitudes (2). Ventricular repolarization occurs in a
geometricpatternacross theheart. Thisprocess entails differences
in timings of recovery across the ventricular wall and between
regions of the left ventricle after ventricular depolarization. The
cellular basis for the origins of the ST-segment and adjacent
Twave (ST-Twave) amplitudes is still under debate, but is general-
ly thought to arise as a consequence of electrical heterogeneities
that exist within the ventricular myocardium (3). It is thought
that the ST-Twave beginswhen the epicardial cells start to recover
aheadof themidwall and endocardial cells. Electrical currentsﬂow
from the midmyocardial and endocardial regions toward the epi-
cardium, resulting in a gradual rise in current, until the epicardium
is fully repolarized and the currents have reached maximal inten-
sity (T-top) (4). Continuous indices of T-wave amplitudes are not
only relevant in patients with myocardial infarction (5), ischemic
cardiomyopathy (6) and a malignant form of ER (7), but also in
non-diseased population cohorts. In the general or healthy popu-
lation, inversions of the ST-Twave are stronglyassociatedwith ad-
verse outcome (8–10), but also minor depressions or elevations in
ST-T-wave amplitudes are predictors of cardiovascular mortality
(11–13) and disease (10,14).
Deviations of ST-T-wave amplitudes can be indicative of a
variety of cardiac pathologies, including myocardial ischemia,
ventricular hypertrophy, long-QT syndrome, ER and Brugada
syndrome (2,8,12,15–17). For clinical use, phenotypes are di-
chotomized based on optimal sensitivity and speciﬁcity to pre-
dict worse outcome. However, there is no evidence that the
underlying biology of ST-T wave is truly binary. Therefore, we
hypothesized that common genetic variation involved in the
biology of quantitative ST-T waves traits might provide add-
itional biological insights into the (patho)physiological me-
chanisms of repolarization. GWAS have proven to be a
powerful and unbiased tool to identify novel mechanisms and
pathways.
Here, we aim to identify key genetic loci associated with the
heart’s repolarization phase during the ST-T wave of the
electrocardiogram (ECG) to further advance our knowledge on
biological factors regulating cardiac repolarization and thereby
provide new gene targets for future study.
Results
Genome-wide discovery analysis and replication
We performed genome-wide meta-analyses in 15 943 subjects of
European descent on the ST-T wave (Supplementary Material,
Table S1), with up to 2 316 136 directly genotyped and imputed
autosomal single nucleotide polymorphisms (SNPs). Phenotypes
for the ST-segment amplitudes and T-wave amplitudes were de-
rived from leads used in the clinic for diagnosing Brugada syn-
drome (17) (Septal, V1 and V2) and early repolarization (ER) (16–
18) (lateral: I, aVL, V5, V6 and inferior: II, III, aVF). Aiming to cap-
ture additional information available on the ECG during cardiac
repolarization, we also investigated the other lead recordings
(Anterior: V3, V4 and lead aVR) that are presumed to have ana-
tomical meaning (Supplementary Material, Table S2). This re-
sulted in 10 phenotypes representing the ST-T-wave amplitude:
5 ST-segment amplitudes and 5 T-wave amplitudes (Fig. 1A).
We estimated that studying 10 correlated ST-T wave phenotypes
was equal to studying eight independent phenotypes (see the
‘Materials andMethods’ section); therefore, the threshold of gen-
ome-wide signiﬁcance was set to P < 5 × 10−8/8 (P < 6.25 × 10−9).
We considered a threshold of P < 1 × 10−6 to be suggestive of as-
sociation and used this threshold to prioritize SNPs for replica-
tion. The genome-wide meta-analysis across the 10 ST-T-wave
phenotypes identiﬁed a total of 36 loci to pass the suggestive
threshold for association with at least one of the ST-T wave
phenotypes. There was no evidence for inﬂation of test statis-
tics in the ﬁnal meta-analysis (Supplementary Material,
Table S3) or signiﬁcant heterogeneity. Of the 36 loci, there were
multiple loci were associated with one or more 10 ST-T-wave
phenotypes: totaling 95 genotype–phenotype associations (P < 1
× 10−6, Supplementary Material, Table S4).
Next, we performed replication testing of the 95 genotype–
phenotype associations (P < 1 × 10−6) in 22 034 independent
individuals derived from 7 independent cohorts (Supplementary
Material, Table S5), identifying 71 genotype–phenotype associa-
tions in 28 independent loci to be replicated (P < 0.01) and become
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genome-wide signiﬁcantly associated (Fig. 1B, Table 1 and Sup-
plementary Material, Table S4 and Fig. S1).
The majority of loci that show multiple genotype–phenotype
associations in the same locus consist of sentinel SNPs that are
either the same SNP or in LD with each other, as indicated by
the LD (r2) column in Table 1. Conditional analysis within the dis-
covery set revealed a secondary signal [rs9851710 conditioned on
rs6801957: β (SE) perminor allele = 0.13 (0.0204), P = 2.38 × 10−10] in
the SCN5A/SCN10A locus to be associated with ST aVR ampli-
tudes. This SNP has also been identiﬁed to be associated with
other ST-T phenotypes (see Table 1), suggesting that there are
29 independent signals within the 28 loci.
Some loci were predominantly associated with ST-segment
amplitudes (locus 4, 5, 16, 26 and 28) while others were predomin-
antly associated with T-wave amplitudes (locus 6, 18 and 29). The
test statistics for every combination of genotype–phenotype asso-
ciation are summarized in Supplementary Material, Table S6.
Other electrocardiographic traits
Previous genome-wide associations have studied other ECG indi-
ces (1,19–23) such as QRS duration, PR interval, heart rate and QT
interval. We intersected these previously identiﬁed loci with our
ST-T-wave loci and found overlap (within 2 MB) in 13 loci. Lead
SNPs from previous and current ﬁndings in 4 loci were in low
LD (r2 < 0.02), suggesting that 19 of the current loci are novel asso-
ciations with the ECG (Supplementary Material, Table S7).
Heritability estimates
The 28 identiﬁed sentinel SNPs collectively explained between
1.6% (T-wave septal) and 5.1% (ST-segment aVR) of the observed
phenotypic variance (Supplementary Material, Table S8). Famil-
ial heritability estimates in the Erasmus Rucphen Family (ERF)
study varied between h2 = 30% (T-wave inferior) and h2 = 42%
(ST septal) suggesting additional genetic variants and other me-
chanisms that remain to be discovered (Supplementary Material,
Table S9). The variation in proportion of variance associatedwith
covariates varied more widely; between r2 = 0.09 (ST-segment in-
ferior) and r2 = 0.36 (ST-segment septal).
Identiﬁcation of candidate genes and pathway analyses
In total, we prioritized 54 candidate genes in the 28 genetic loci
(Table 1) that could play a causal role in ST-T-wave amplitudes
based on several criteria, as described in the ‘Materials and
Figure 1. (A) We conducted genome-wide analyses of ST-segment amplitudes at 80 ms after J-point and T-wave (top) amplitudes reﬂecting temporal patterns in the
cardiac cycle during the repolarization phase. In total, 12 phenotypes were deﬁned by taking the sum of the ST-T-wave amplitudes in the lateral (I, aVL, V5 and V6),
inferior (II, III and aVF), septal (V1 and V2), anterior (V3 and V4) leads and lead aVR. These lead groups cover the combination of leads with presumed anatomical
meaning of the heart, and those that are used in the clinic for diagnosing Brugada syndrome (17) and ER (16–18). (B) Genome-wide association analyses of all ST-T
wave traits identiﬁed 71 signiﬁcant genotype–phenotype associations in 28 genetic loci (2 MB). The x-axis represents the chromosomal position for each SNP, which
was assigned the lowest P-value across the 12 traits; the y-axis represents the −log10 of the P-value for association. Twenty-seven loci were signiﬁcant for ST-T-wave
amplitudes. (C) Four genes overlapping four loci are directly involved in the cardiac action potential; SNPs near SCN5A were associated with ST-segment and T-top
amplitudes whereas the loci containing potassium channel-coding genes KCND3, KCNA7 and KCNB1 were primarily associated with ST-segment amplitudes.
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Table 1. All sentinel SNP associations per ST-T wave phenotype
No. Region SNP Trait LD (r2) with Sentinel
SNP (†) in Locus
EA (FRQ)/NEA β (SE) Pmeta N Gene
1 1p36.33 rs260505 T.ant † A (0.49)/C 0.05 (0.01) 1.30E-11 37775 SKIn
2 1p36.12 rs2072944 T.sep 0.37 T (0.55)/C 0.05 (0.01) 1.70E-13 37821 LUZP1n, KDM1An, WNT4e
2 1p36.12 rs2298632 ST.sep † T (0.47)/C −0.07 (0.01) 4.40E-18 37753 TCEA3ne
3 1p31.3 rs2207792 T.aVR – A (0.66)/G −0.06 (0.01) 3.30E-13 37799 NFIAnd
3 1p31.3 rs2207792 T.inf † A (0.66)/G 0.07 (0.01) 3.00E-20 37810 NFIAnd
4 1p13.2 rs12145374 ST.ant – A (0.76)/C 0.11 (0.01) 5.90E-33 37753 KCND3ng, FAM212Bd
4 1p13.2 rs12145374 ST.sep – A (0.76)/C 0.07 (0.01) 1.20E-14 37753 KCND3ng, FAM212Bd
4 1p13.2 rs12145374 ST.aVR – A (0.76)/C −0.12 (0.01) 1.40E-31 37784 KCND3ng, FAM212Bd
4 1p13.2 rs12145374 ST.lat † A (0.76)/C 0.12 (0.01) 8.20E-34 37771 KCND3ng, FAM212Bd
4 1p13.2 rs12145374 ST.inf – A (0.76)/C 0.09 (0.01) 6.00E-18 37770 KCND3ng, FAM212Bd
5 1q22 rs10908505 ST.aVR † A (0.66)/T −0.05 (0.01) 1.70E-11 37784 MEF2Dngd
6 1q23.3 rs12567315 T.ant 0.42 A (0.19)/G −0.06 (0.01) 4.60E-11 37775 NOS1APn
6 1q23.3 rs4657178 T.inf † T (0.24)/C −0.06 (0.01) 1.90E-11 37810 NOS1APn
7 1q24.2 rs545833 ST.ant † T (0.26)/C −0.06 (0.01) 7.00E-18 37753 DPTn
7 1q24.2 rs511187 ST.inf 0.79 A (0.72)/G 0.06 (0.01) 2.60E-12 37770 DPTn
7 1q24.2 rs511187 ST.aVR 0.79 A (0.72)/G −0.07 (0.01) 3.10E-17 37784 DPTn
7 1q24.2 rs511187 ST.lat 0.79 A (0.72)/G 0.07 (0.01) 7.20E-18 37771 DPTn
8 2p15 rs7576036 ST.sep † T (0.54)/C 0.05 (0.01) 2.80E-10 37753 XPO1n
9 2q33.1 rs1866666 T.aVR † T (0.49)/C −0.05 (0.01) 1.80E-11 37799 PLCL1nced, MARS2e, RFTN2e,
MOB4d
10 3p25.1 rs4684185 T.aVR † T (0.35)/C −0.05 (0.01) 7.10E-10 37799 LSM3n, TMEM43d
11 3p22.2 rs7638909 ST.sep 0.02 T (0.76)/G −0.06 (0.01) 2.00E-11 37753 SCN5And, ACVR2Bd
11 3p22.2 rs9851710* T.inf 0.03 A (0.66)/C 0.08 (0.01) 9.30E-19 37810 SCN10An, SCN5Ad, ACVR2Bd
11 3p22.2 rs7633988 T.ant 0.02 A (0.71)/T 0.06 (0.01) 3.80E-11 37775 SCN10An, SCN5Ad, ACVR2Bd
11 3p22.2 rs6783110 T.lat 0.94 A (0.42)/G 0.06 (0.01) 3.70E-12 30699 SCN10Anc, SCN5Ad, ACVR2Bd
11 3p22.2 rs4076737 T.aVR 0.93 T (0.57)/G 0.07 (0.01) 1.20E-20 37799 SCN10Anc, SCN5Ad, ACVR2Bd
11 3p22.2 rs4076737 ST.inf 0.93 T(0.57)/G −0.07 (0.01) 8.30E-20 37770 SCN10Anc, SCN5Ad, ACVR2Bd
11 3p22.2 rs6801957 ST.aVR † T (0.43)/C −0.08 (0.01) 1.10E-25 37784 SCN10Anc, SCN5Ad, ACVR2Bd
11 3p22.2 rs6801957 ST.lat – T (0.43)/C 0.06 (0.01) 8.50E-16 37771 SCN10Anc, SCN5Ad, ACVR2Bd
12 6p21.31 rs7756236 ST.ant † A (0.76)/G −0.06 (0.01) 1.30E-14 37753 CDKN1Aned
13 6q22.2 rs210966 ST.lat – C (0.28)/G 0.07 (0.01) 5.10E-16 37771 ROS1n, VGLL2d
13 6q22.2 rs210966 ST.aVR † C (0.28)/G −0.07 (0.01) 4.00E-18 37784 ROS1n, VGLL2d
13 6q22.2 rs172409 ST.inf 0.41 A (0.54)/C −0.05 (0.01) 6.40E-11 30708 ROS1n, VGLL2d
14 6q22.31 rs9388451 ST.ant † T (0.52)/C −0.06 (0.01) 2.00E-18 37753 HEY2ned
14 6q22.31 rs9388451 T.ant – T (0.52)/C −0.05 (0.01) 3.60E-13 37775 HEY2ned
15 8p23.1 rs1458942 ST.aVR † A (0.60)/G 0.06 (0.01) 1.10E-13 37784 TNKSnd, SGK223d, XKR6d,
PPP1R3Bd
16 8p23.1 rs7011924 ST.aVR † A (0.40)/G 0.07 (0.01) 1.30E-19 37784 DEFB136n, NEIL2e
16 8p23.1 rs7011924 ST.inf – A (0.40)/G −0.07 (0.01) 3.90E-19 37770 DEFB136n, NEIL2e
17 12p13.32 rs7953399 ST.sep 0.95 A (0.61)/G −0.04 (0.01) 2.10E-09 37753 GALNT8n
17 12p13.32 rs2286582 ST.ant † T (0.40)/C 0.06 (0.01) 2.40E-16 37753 GALNT8n
18 12p12.1 rs10842350 T.lat – A (0.54)/G −0.09 (0.01) 4.60E-37 37759 SOX5ng
18 12p12.1 rs10842350 T.aVR † A (0.54)/G 0.09 (0.01) 1.30E-37 37799 SOX5ng
19 12q24.21 rs10850409 T.sep † A (0.27)/G 0.07 (0.01) 4.30E-17 34881 TBX3n
20 13q22.1 rs728926 T.lat † T (0.38)/C −0.07 (0.01) 2.00E-18 37759 KLF12n
20 13q22.1 rs728926 T.aVR – T (0.38)/C 0.06 (0.01) 1.50E-16 37799 KLF12n
21 15q26.3 rs7174918 ST.ant 0.74 T (0.29)/C −0.06 (0.01) 6.90E-16 37753 IGF1Rnd
21 15q26.3 rs3803476 T.sep – A (0.37)/G −0.05 (0.01) 2.00E-14 37821 IGF1Rnd
21 15q26.3 rs3803476 ST.sep † A (0.37)/G −0.07 (0.01) 1.80E-23 37753 IGF1Rnd
22 16p13.3 rs7192150 T.aVR † A (0.40)/G 0.05 (0.01) 4.30E-13 37799 LMF1ne, SOX8gd
23 16p13.13 rs7191330 T.aVR 0.95 T (0.46)/C −0.08 (0.01) 3.10E-16 30731 LITAFn
23 16p13.13 rs735951 ST.ant – A (0.47)/G 0.06 (0.01) 9.50E-17 37753 LITAFn
23 16p13.13 rs735951 ST.aVR – A (0.47)/G −0.07 (0.01) 1.70E-18 37784 LITAFn
23 16p13.13 rs735951 ST.lat † A (0.47)/G 0.07 (0.01) 1.20E-18 37771 LITAFn
24 16q21 rs4784938 ST.lat 0.7 A (0.74)/G 0.08 (0.01) 4.80E-21 37771 GINS3n
24 16q21 rs4784939 ST.ant – T (0.36)/C −0.09 (0.01) 4.80E-41 37753 GINS3n
24 16q21 rs4784939 T.ant – T (0.36)/C −0.06 (0.01) 1.00E-17 37775 GINS3n
24 16q21 rs4784939 T.sep – T (0.36)/C −0.08 (0.01) 4.10E-29 37821 GINS3n
24 16q21 rs4784939 ST.sep † T (0.36)/C −0.11 (0.01) 3.00E-57 37753 GINS3n
24 16q21 rs8057901 T.aVR 0.93 A (0.63)/G −0.06 (0.01) 4.90E-11 30731 NDRG4n
24 16q21 rs8057901 ST.aVR 0.93 A (0.63)/G −0.08 (0.01) 1.60E-21 30713 NDRG4n
Table continues
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Methods’ section. Thirty-four geneswere prioritized based on the
proximity criteria, 5 genes contained one or more non-
synonymous SNPs in high LD with a lead SNP (Supplementary
Material, Table S10), 12 genes had a top-eQTL SNP in high LD
with a lead SNP (Supplementary Material, Table S11), 65 genes
were selected by the data-driven expression prioritized integra-
tion for complex trait (DEPICT) analysis of which 25 were within
genome-wide signiﬁcant loci (at false discovery rate ≤ 5%; Sup-
plementary Material, Table S12) and 3 genes are based on litera-
ture mining using GRAIL (Supplementary Material, Table S13).
The top ﬁve keywords retrieved from GRAIL were ‘muscle’,
‘channel’, ‘transcription’, ‘heart’ and ‘channels’.
The DEPICTmethod (24) was applied to subsequently offer in-
sight into the biological pathways underlying changes in ST-T-
wave amplitudes of the ECG. DEPICT identiﬁed 56 reconstituted
gene sets, which grouped into 9 distinct clusters. The cluster con-
taining the most signiﬁcantly enriched reconstituted gene set
(‘VCL protein complex’, a protein–protein interaction network
centered on the Vinculin gene product, P = 6.00 × 10−6) repre-
sented various protein complexes likely related to Fascia Adhe-
rens, while the second most signiﬁcant gene cluster ‘Abnormal
Cardiovascular System Physiology’ contains reconstituted gene
set known to be important for cardiac repolarization (Fig. 2 and
Supplementary Material, Table S14).
Role of regulatory DNA and 1000 genomes imputation
ST-T-wave associated SNPs were 3-fold enriched in Dnase1
Hypersensitivity sites (DHSs) from human fetal heart (Fig. 2),
which was signiﬁcantly higher compared with 337 other cell
types and tissues (P = 0.0004, Z-score statistics) in linewith earlier
observations (25,26). We then performed ﬁne mapping of all 71
genome-wide signiﬁcant genotype–phenotype associations
(Table 1) in prevention of renal and vascular end-stage disease
(Prevend) and Lifelines imputed with 1000 genomes (1000G),
covering more of the known common variants in humans. We
observed that 64 (of 71) associations were assigned to a different
lead SNP, that 63 of these associations were more signiﬁcant in
the 1000G imputed data and effect estimates were higher for 58
of these associations (Supplementary Material, Table S16). To fa-
cilitate future functional experiments toward the identiﬁcation
of causal variants and their underlying biological mechanisms,
we prioritized potential causal SNPs using the probabilistic
framework of Probabilistic Annotation INTegratOR (PAINTOR)
(27). PAINTOR determined the signiﬁcance of each annotation
(Fig. 2) and used the ﬁve most signiﬁcant annotations (conserva-
tion scores, DHS of fetal heart, enhancers of the left ventricle and
Tbx3 bound regions) to prioritize potential causal SNPs in the 28
loci (27). This yielded 315 SNPs in the 99% conﬁdence set and 96
SNPs in the 95% conﬁdence set (Supplementary Material,
Table S17).
Discussion
Amplitudes of the ST segment and T wave are important traits
that are associated with abnormal heart rhythm, conduction dis-
turbances and ventricular arrhythmias. In this study, we per-
formed the ﬁrst GWAS of ST-T-wave amplitudes of the ECG in
up to 37 977 individuals. Traits were deﬁned according to the
combination of ECG leads presumed to have anatomicalmeaning
or used in the clinic for diagnosing Brugada syndrome and early
repolarization (16–18). ST-T-wave traits were moderately herit-
able (h2 = 30–42%) while the proportion of variance associated
with covariates (gender, bodymass index and age) varied consid-
erably (9–36%) strongly supporting the genetic background of
these traits. We identiﬁed 28 genome-wide signiﬁcant loci for
ST-T-wave amplitudes and a set of 54 candidate genes.
A recent GWAS on Brugada syndrome revealed the associ-
ation of two loci that are shared by our ST-T-wave loci (28). One
of these signals in the SCN5A/SCN10A locus is in complete LD
with our sentinel SNP (rs10428132, r2 = 0.96 with rs6801957) and
rs9388451 near HEY2, is a ST-T-wave sentinel SNP; suggesting
that Brugada syndrome susceptibility loci share a common gen-
etic backgroundwith ST-T-wave traits. One of the strongest asso-
ciated GWAS signals for all amplitudes of the ST segment was in
the KCND3 gene (locus 4). KCND3 encodes the Kv4.3 α-subunit
that conducts the cardiac fast transient outward K+ current
(ITo,f ). This current is prominent in Phase 1 of the action potential
Table 1. Continued
No. Region SNP Trait LD (r2) with Sentinel
SNP (†) in Locus
EA (FRQ)/NEA β (SE) Pmeta N Gene
24 16q21 rs8057901 ST.inf 0.93 A (0.63)/G 0.07 (0.01) 1.30E-16 30708 NDRG4n
24 16q21 rs9940062 T.inf 0.94 T (0.68)/G 0.07 (0.01) 1.20E-10 30738 NDRG4n
25 18q12.1 rs8083566 ST.lat – A (0.07)/C −0.09 (0.01) 4.30E-10 37771 CDH2nd
25 18q12.1 rs8083566 ST.inf – A (0.07)/C −0.11 (0.02) 1.70E-12 37770 CDH2nd
25 18q12.1 rs8083566 ST.aVR † A (0.07)/C 0.12 (0.01) 3.60E-15 37784 CDH2nd
26 19q13.33 rs11673003 ST.lat † A (0.90)/G −0.09 (0.01) 5.10E-14 37771 KCNA7nc, NTF4n, GYS1d, HRCd
27 20q11.22 rs6087666 ST.inf † A (0.20)/G −0.07 (0.01) 3.10E-15 37770 TRPC4APne, EDEM2ce,
MYH7Bcd, NCOAd
27 20q11.22 rs6088738 ST.aVR 0.55 A (0.21)/G 0.06 (0.01) 5.90E-13 37784 EDEM2ne, PROCRe, MYH7Bcd,
NCOAd
28 20q13.13 rs11907908 ST.ant 0.83 T (0.07)/C −0.12 (0.01) 8.00E-18 37753 ZNFX1 (−AS1)n, STAU1d
28 20q13.13 rs6019750 ST.lat 1 C (0.93)/G 0.13 (0.01) 4.30E-23 37771 KCNB1n, STAU1d
28 20q13.13 rs2202261 ST.inf – A (0.93)/G 0.12 (0.01) 4.40E-18 37770 KCNB1n, STAU1d
28 20q13.13 rs2202261 ST.aVR † A (0.93)/G −0.14 (0.01) 5.60E-26 37784 KCNB1n, STAU1d
There are 71 genome-wide signiﬁcant genotype–phenotype associations clustered in 28 genetic loci (based on a 2 MB locus deﬁnition, see the ‘Materials and Methods’
section). Gene superscripts indicate the method of identiﬁcation: n, nearest gene or nearby gene (within 10 kb of the SNP); g, Grail’ d, Depict; e, eQTL; c, coding SNP
(non-synonymous). rs9851710 denoted by an asterisk (*) indicates that this SNP is an independent, secondary, association for ST.aVR (rs9851710 conditioned on
rs6801957: β (SE) per minor allele = 0.13 (0.0204), P = 2.38 × 10−10).
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and contributes to the ‘notch’ of the cardiomyocyte’s action
potential (2). Mutations in KCND3 have been implicated with in-
creased risk of sudden cardiac death (29,30), as well as mutations
in SCN5A (2) and SCN10A (31). We speciﬁcally identiﬁed loci
containing potassium channels KCND3 (locus 4), KCNB1 (locus
28) and KCNA7 (locus 26) to be predominantly associated with
amplitudes of the ST segment and not with the T wave, suggest-
ing that these potassium channels are activated during the ST
Figure 2. (A) DEPICT identiﬁed 56 signiﬁcantly enriched gene-sets relevant for ST-T-wave amplitudes. (B) SNPs were signiﬁcantly more enriched in DHSs of fetal heart
tissue (n = 12) compared with other tissue and cells (n = 337), across the full range of P-values of the discovery meta-analyses (genome wide), suggesting that
functionality of regulatory DNA elements may underlie some of the associations. (C and D) Next, we performed a meta-analysis of the 28 identiﬁed ST-T wave loci
using 1000 Genomes imputed data, for this 1000G variants needed to be in LD r2 > 0.1 with the HapMap sentinel SNP. Subsequent prioritization of potential causal
annotations in these loci also suggested that regions of DHS in fetal heart are possibly underlying the associations as well as cardiac transcription factors, conserved
regions (exonic), active and weak enhancers. While regions that are transcribed, tightly packed (heterochromatin) or function as promoters in the ventricles may be
less important for the biological mechanisms of genetic variants that are associated with ST-T-wave amplitudes. Subtle difference are present between the ventricles
and fetal heart which could suggest that promoters that overlap potential causal ST-T wave SNPs may be active in the fetal heart but repressed in the ventricles.
Percentages between parentheses indicate the amount of SNPs in the 28 loci overlapping with the annotation. Conservation (GERP and 29 mammals), DHS of fetal heart,
enhancers of the left ventricle and Tbx3 bound regions were used to prioritize potential causal SNPs in the 28 loci.
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segment of the repolarization phase and may have clinical rele-
vance (16,32,33). Future studies are required to examine the
potential role of the other ST-T-wave SNPs for increased arrhyth-
mogenic risk and sudden death through an altered cardiac
repolarization.
In addition toHEY2, a transcriptional regulator of cardiac elec-
trical function in the right ventricular outﬂow tract (28), we iden-
tiﬁed six loci containing genes with strong evidence of being
directly involved in cardiac tissue development via transcription-
al regulatory pathways. Locus 5 contains a myocyte enhancer
factor-2 (MEF2D) important for cardiac muscle morphogenesis
and heart looping (34,35). Loci 18 and 22 contain two transcrip-
tion factors from the SOX family, SOX5 and SOX8. SOX5 is import-
ant for a functioning heart and involved in correct Wnt signaling
(36). This locus has previously been associated with the PR inter-
val and resting heart rate, but the identiﬁed variant in the current
study is in low LD (r2 = 0.01), suggesting multiple molecular-gen-
etic mechanisms at this locus to inﬂuence heart function. Tran-
scripts of SOX8 are concentrated in the subendothelial
mesenchym of the whole outﬂow tract (37) in which N-Cadherin
(38) (encoded by CDH2, locus 25), the transcription factor Tbx3
(39) (TBX3, locus 19) and WNT4 (40) (speciﬁc for the endocardial
endothelial cushion development, part of the Wnt pathway) in
locus 2 also play essential developmental roles, among other
cardiac cell lineages. Other compelling cardiac genes are: SKI,
for which mutations (1p36 deletion- and Sprintzen–Goldberg
syndrome) are characterized by heart defects, brain abnormal-
ities and muscle tone (hypotonia) in infancy (41); TMEM43
(locus 10) in which mutations cause arrhythmogenic right
ventricular cardiomyopathy and Emery–Dreifuss muscular dys-
trophy; the sarcomeric gene MYH7B and miR499 (locus 27),
which regulates a multitude of cardiac mRNA and microRNAs
and promotes ventricular speciﬁcation; and GALNT1, a glycosyl-
transferases that is required for normal heart valve development
and cardiac function by regulating the extracellular matrix and
altering conserved signaling pathways that regulate cell prolifer-
ation during heart development (42).We also identiﬁed a number
of less well-characterized genes, which should be explored in
further research.
Five of the 28 ST-T-wave sentinel SNPs were in LD with SNPs
associatedwith QT duration (1), suggesting that ST-T-wave ampli-
tudes provides additional information on cardiac repolarization.
The known functions of the candidate genes and our pathway
analyses suggest that the ST-T-wave amplitudes are inﬂuenced
and regulated by awide variety ofmolecularmechanisms, includ-
ing ion-channels, structural proteins and cardiac transcription
factors. However, the ﬁnding that protein complexes related to
Fascia Adherens are most enriched in our pathway analyses
hints that some of the biology underlying ST-T waves is less well
captured in well-established pathways and better represented by
data-driven (and not manually curated) pathways.
Ventricular repolarization is a complex process. To capture
this process, we chose to apply a selection of composite ECG
parameters with the aim of gaining more insight into the bio-
logical processes underlying the ST-T wave. These surface ECG
parameters are not speciﬁc enough to identify the exact anatom-
ical region of the heart; e.g. the septal leads (V1 and V2) may also
include aspects of the right ventricular wall activity. However,
there are no data available of more precise measurements such
as could be derived from more sophisticated surface ECG equip-
ment or intra-cardiac ECG measurements.
In summary, we present a large number of genome-wide
signiﬁcant loci robustly associated with cardiac repolarization
parameters, some with compelling biological basis for their
association and a number of loci not previously implicated in car-
diac function. The identiﬁed loci and selected genes have the po-
tential to aid future studies that are focused on risk stratiﬁcation
or on molecular mechanisms underlying cardiac repolarization
and diseases of cardiac repolarization; to facilitate these studies,
we have made our results (including the genome-wide associ-
ation) publicly available.
Materials and Methods
Study populations
The discovery phase included participants of the Prevend study
and the Lifelines study cohort. Both are community-based cohort
studies from the northern part of the Netherlands. The replica-
tion phase included participants of the Atherosclerosis Risk in
Communities study (ARIC), Cardiovascular Health Study (CHS),
Young Finns Study (YFS), ERF study, Rotterdam study I, II and
III (RS I, II and III). Detailed descriptions of each cohort are
given in the supplementary material. Characteristics of partici-
pants are summarized in Supplementary Material, Tables S1
and S5. Detailed Information on genotyping methods, quality
control of SNPs, imputation and statistical analysis for each
cohort is summarized in Supplementary Material, Table S18.
Phenotype modeling
Summing correlated variables when expecting that genetic var-
iants are associated to multiple of these variables will increase
the power for detection; with genetic variant (Snp), and traits
(Ampitudei), consider the correlation: Corr(Snp, Ampitude1 +
Ampitude2) = Corr(Snp, Ampitude1) + Corr(Snp, Ampitude2) + 2 × Corr
(Ampitude1, Ampitude2) >Corr(Snp, Ampitude1) +Corr(Snp, Ampitude2),
hence if Corr(Ampitude1, Ampitude2) > 0, the traits Ampitudei meas-
ure the same latent variable (L). Therefore, phenotypes for the ST-
segment amplitudes 80 ms after J-point and T-wave amplitudes
were deﬁned by taking the sumof the lateral (I, aVL, V5 and V6), in-
ferior (II, III and aVF), septal (V1 and V2), anterior (V3 and V4) leads
and leadaVR. Individualswere excluded for bundlebranchblockor
QRS duration > 120 ms, atrial ﬁbrillation, ﬂutter, history ofmyocar-
dial infarction or electronic pacemaker rhythm and when avail-
able, heart failure and ECG altering medication. Also participants
with extreme measurements (more than ±4SD from mean) were
excluded on a per phenotype basis.
Statistical analyses
To control for multiple testing of the 10 phenotypes while
accounting for the correlation between them, we performed an
eigenvalue decomposition of the correlationmatrix (Supplemen-
tary Material, Table S2) of the phenotypes. The variance of the
eigenvalues [Var (λobs) = 2.36] was used to estimate the effective
number of independent phenotypes tested (43). Our ﬁndings
indicate that studying 10-related ST-T-wave traits is equivalent
to analysis of 8 independent phenotypes. We, therefore, adopt
αa = 5 × 10
−8/8 = 6.25 × 10−9 as threshold for declaring genome-
wide signiﬁcance in order to correct for the effective number of
independent phenotypes studied.
Residuals of ST-T-wave amplitudes were calculated using
general linear regression models to adjust for age, gender and
bodymass index and standardized to amean of zero and a stand-
ard deviation of one. GWAS analyses in Prevend and Lifelines of
2 316 136 genotyped or imputed SNPs (Supplementary Material,
Table S18) were performed on the standardized residuals using
an additive genetic model in PLINK (v.1.07). Phenotypes were
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normally distributed (Supplementary Material, Fig. S2). Test sta-
tistics from each cohort were then corrected for their respective
genomic control inﬂation factor to adjust for residual population
sub-structure and meta-analyzed using the inverse-variance
method. SNPs with minor allele frequency < 1% (weighted aver-
age across cohorts) were removed. Variants were considered to
be independent if the pair-wise LD (r2) was <0.1 and if they
were separated by at least 1 MB; this was deﬁned a ‘locus’. We se-
lected one sentinel SNP (themost-signiﬁcantly associated SNP in
a locus) for each genotype–phenotype combination.
For conditional analyses, we repeated the primary association
analysis for each trait while conditioning on the trait-speciﬁc
genome-wide signiﬁcant sentinel SNPs by adding the SNP geno-
types as covariates. Association results for each studywere again
combined by inverse variance weighting.
Replication of the signiﬁcant genotype–phenotype associa-
tions (P < 6.25 × 10−9) and associations that did not exceed this
threshold, but were suggestive (6.25 × 10−9 < P <1 × 10−6), was per-
formed in the RS I, II and III, ERF, ARIC, CHS and YFS and com-
bined using ﬁxed-effects meta-analysis by inverse variance
weighting (SupplementaryMaterial, Table S18). The pre-speciﬁed
statistical signiﬁcance threshold for heterogeneity by Cochran’s
Q (Phet) was Phet < 0.0007 to account for multiple testing. Inverse
variance weighting was used to determine meta-P-values for
combined discovery and replication data. An association was
considered replicated if the direction of effect was concordant
with discovery, replication P < 0.01 and meta-P < 6.25 × 10−9.
Heritability estimates were calculated in the ERF study using
the ‘tdist’ function in the SOLAR software, including gender,
age and body mass index as covariates.
Data-driven expression prioritized integration for
complex traits
DEPICT systematically identiﬁes the most likely causal gene at a
given associated locus, tests gene sets for enrichment in asso-
ciated SNPs, and identiﬁes tissues and cell types in which
genes from associated loci are highly expressed [see Pers et al.
(24) for a detailed description]. For this work, we ran DEPICT on
140 independently associated loci (association P < 10−5; PLINK
parameters, ‘–clump-p1 1e-5 –clump-kb 500 –clump-r2 0.05’) re-
sulting in 103 independent, autosomal DEPICT loci containing
363 genes (loci overlapping with the major histocompatibility
complex region are by default excluded in DEPICT). We have
extended the locus deﬁnition used in DEPICT (LD r2 > 0.5) with
100 kb at either side of the loci, because several genes that may
be important for cardiac repolarization were outside the default
DEPICT locus boundaries (e.g. SCN5A, TMEM43 and VGLL2). The
gene set enrichment results for this slightly extended locus
deﬁnition were similar to the results based on the default locus
deﬁnition used in DEPICT (Supplementary Material, Table S19).
Identiﬁcation of candidate genes
We prioritized candidate genes based on nearby genes: we consid-
ered the nearest gene and any other gene located within 10 kb of
the sentinel SNP. Coding variants: for identiﬁcation of coding
variants and LD calculations, we used the 1000G Project data
set (March 2012 release) in the European populations.We consid-
ered genes that harbor non-synonymous SNPs in LD with the
ST-T-wave SNPs at r2 > 0.8. GRAIL analyses: we carried out a
literature analysis by employing the GRAIL text-mining algo-
rithm, a statistical tool that identiﬁes subsets of genes with
known functional interrelationships based on PubMed abstracts.
We carried out the analysis using the 2006 data set to avoid con-
founding by subsequent GWAS discovery. The DEPICT method
(see above), and expression QTL (eQTL) analyses in cis, we search
for eQTLs (sentinel SNPs or SNPs in LD, r2 > 0.8, HapMap r27) in
an eQTL data set that was compiled from the summary statistics
of various studies and tissues (see SupplementaryMaterial, Table
S11). We only considered eQTLs that were in LD (r2 > 0.8, HapMap
r27)with the sentinel SNPand reached a P-value cut-off of at least
P < 0.05/(28 loci × 17 eQTL studies).
Imputation using 1000G
Genome positions from the Prevend and Lifelines genotypes were
converted from hg18 to hg19 using the UCSC LiftOver tool. Gen-
ome-wide genotype imputation was performed with SHAPEIT (v2)
and IMPUTE2 (v2.3.0) using the complete 1000 Genomes v3, March
2012 haplotypes Phase I integrated variant set release as reference
panel.
Functional information
We overlapped SNPs with data from the ENCODE project (44) and
Roadmap Epigenomics Program (45), conservation across mam-
mals, various cardiac transcription factor measured by ChIP-Seq
and contiguous annotations of the human fetal heart, left ventricle
and right ventricle as determined byChromHMM (46) (Supplemen-
tary Material).
Prioritization of potentially causal variants and
enrichment of DNA elements
For the prioritization of genetic variants for the future functional
follow-up and insight of the underlying DNA elements that
might be relevant for causal ST-T-wave amplitude variants, we
employed the PAINTOR framework (27). In short, this method al-
lows us to prioritize genetic variants in each of the 28 signiﬁcant
associated loci by an integrating strength of association and an-
notations of functional DNA elements to estimate the probability
for each variant to be causal, but also investigate which annota-
tions are potentially causal.
Supplementary Material
Supplementary Material is available at HMG online.
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